Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Impact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan.

Hung YP, Tsai PJ, Hung KH, Liu HC, Lee CI, Lin HJ, Wu YH, Wu JJ, Ko WC.

PLoS One. 2012;7(8):e42415. doi: 10.1371/journal.pone.0042415. Epub 2012 Aug 2.

2.

Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.

Lin HJ, Hung YP, Liu HC, Lee JC, Lee CI, Wu YH, Tsai PJ, Ko WC.

J Microbiol Immunol Infect. 2015 Apr;48(2):183-9. doi: 10.1016/j.jmii.2013.08.003. Epub 2013 Sep 21.

3.

Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure.

Hung YP, Lin HJ, Wu TC, Liu HC, Lee JC, Lee CI, Wu YH, Wan L, Tsai PJ, Ko WC.

PLoS One. 2013 Jul 25;8(7):e69577. doi: 10.1371/journal.pone.0069577. Print 2013.

4.

[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].

Deniz U, Ulger N, Aksu B, Karavuş M, Söyletir G.

Mikrobiyol Bul. 2011 Jan;45(1):1-10. Turkish.

PMID:
21341153
5.

Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.

Thipmontree W, Kiratisin P, Manatsathit S, Thamlikitkul V.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S207-16.

PMID:
21721449
6.

Clostridium difficile infection in an Iranian hospital.

Jalali M, Khorvash F, Warriner K, Weese JS.

BMC Res Notes. 2012 Mar 21;5:159. doi: 10.1186/1756-0500-5-159.

7.

A superior test for diagnosis of Clostridium difficile-associated diarrhea in resource-limited settings.

Chotiprasitsakul D, Janvilisri T, Kiertiburanakul S, Watcharananun S, Chankhamhaengdecha S, Hadpanus P, Malathum K.

Jpn J Infect Dis. 2012 Jul;65(4):326-9.

8.

Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan.

Lee YC, Wang JT, Chen AC, Sheng WH, Chang SC, Chen YC.

J Microbiol Immunol Infect. 2012 Aug;45(4):287-95. doi: 10.1016/j.jmii.2011.12.001. Epub 2011 Dec 29.

9.

[Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].

Fernandez Canigia L, Nazar J, Arce M, Dadamio J, Smayevsky J, Bianchini H.

Rev Argent Microbiol. 2001 Apr-Jun;33(2):101-7. Spanish.

PMID:
11494752
10.

Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates.

Koo HL, Van JN, Zhao M, Ye X, Revell PA, Jiang ZD, Grimes CZ, Koo DC, Lasco T, Kozinetz CA, Garey KW, DuPont HL.

Infect Control Hosp Epidemiol. 2014 Jun;35(6):667-73. doi: 10.1086/676433. Epub 2014 Apr 22.

PMID:
24799643
11.

Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases.

Hung YP, Lin HJ, Tsai BY, Liu HC, Liu HC, Lee JC, Wu YH, Wilcox MH, Fawley WN, Hsueh PR, Tsai PJ, Ko WC.

Anaerobe. 2014 Dec;30:188-92. doi: 10.1016/j.anaerobe.2014.06.005. Epub 2014 Jun 21.

PMID:
24956433
12.

The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.

Sadeghifard N, Salari MH, Ghassemi MR, Eshraghi S, Amin Harati F.

Acta Med Iran. 2010 Sep-Oct;48(5):320-5.

13.

Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.

Barbut F, Corthier G, Charpak Y, Cerf M, Monteil H, Fosse T, Trévoux A, De Barbeyrac B, Boussougant Y, Tigaud S, Tytgat F, Sédallian A, Duborgel S, Collignon A, Le Guern ME, Bernasconi P, Petit JC.

Arch Intern Med. 1996 Jul 8;156(13):1449-54.

PMID:
8678714
14.

Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study.

van den Berg RJ, Vaessen N, Endtz HP, Schülin T, van der Vorm ER, Kuijper EJ.

J Med Microbiol. 2007 Jan;56(Pt 1):36-42.

PMID:
17172514
15.

Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan.

Hung YP, Huang IH, Lin HJ, Tsai BY, Liu HC, Liu HC, Lee JC, Wu YH, Tsai PJ, Ko WC.

PLoS One. 2016 Nov 18;11(11):e0166159. doi: 10.1371/journal.pone.0166159. eCollection 2016.

16.

Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study.

Zhang X, Wang X, Yang J, Liu X, Cai L, Zong Z.

BMC Infect Dis. 2016 Aug 9;16:397. doi: 10.1186/s12879-016-1729-2.

17.

Clostridium difficile colonization and diarrhea at a tertiary care hospital.

Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW.

Clin Infect Dis. 1994 Feb;18(2):181-7.

PMID:
8161624
18.

[Risk factors of Clostridium difficile-associated diarrhea in children].

Guo S, Xu XW, Dong F.

Zhonghua Yi Xue Za Zhi. 2012 Jul 10;92(26):1836-40. Chinese.

PMID:
22944235
19.

Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005.

Shin BM, Kuak EY, Yoo HM, Kim EC, Lee K, Kang JO, Whang DH, Shin JH.

J Med Microbiol. 2008 Jun;57(Pt 6):697-701. doi: 10.1099/jmm.0.47771-0.

PMID:
18480325
20.

Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan.

Hsu MS, Wang JT, Huang WK, Liu YC, Chang SC.

J Microbiol Immunol Infect. 2006 Jun;39(3):242-8.

PMID:
16783456

Supplemental Content

Support Center